CRISPR-Cas13a Cascade-based Viral RNA Assay for Detecting SARS-CoV-2 and Its Mutations in Clinical Samples
Overview
Authors
Affiliations
SARS-CoV-2 is one of the greatest threats to global human health. Point-of-care diagnostic tools for SARS-CoV-2 could facilitate rapid therapeutic intervention and mitigate transmission. In this work, we report CRISPR-Cas13a cascade-based viral RNA (Cas13C) assay for label-free and isothermal determination of SARS-CoV-2 and its mutations in clinical samples. Cas13a/crRNA was utilized to directly recognize the target of SARS-CoV-2 RNA, and the recognition events sequentially initiate the transcription amplification to produce light-up RNA aptamers for output fluorescence signal. The recognition of viral RNA via Cas13a-guide RNA ensures a high specificity to distinguish SARS-CoV-2 from MERS-CoV and SARS-CoV, as well as viral mutations. A post transcription amplification strategy was triggered after CRISPR-Cas13a recognition contributes to an amplification cascade that achieves high sensitivity for detecting SARS-CoV-2 RNA, with a limit of detection of 0.216 fM. In addition, the Cas13C assay could be able to discriminate single-nucleotide mutation, which was proven with N501Y in SARS-Cov-2 variant. This method was validated by a 100% agreement with RT-qPCR results from 12 clinical throat swab specimens. The Cas13C assay has the potential to be used as a routine nucleic acid test of SARS-CoV-2 virus in resource-limited regions.
Detection of Potato Pathogen by CRISPR/Cas13a Analysis of NASBA Amplicons.
Khmeleva S, Kurbatov L, Ptitsyn K, Timoshenko O, Morozova D, Suprun E Int J Mol Sci. 2024; 25(22).
PMID: 39596282 PMC: 11595182. DOI: 10.3390/ijms252212218.
Fluorogenic RNA-Based Biosensors of Small Molecules: Current Developments, Uses, and Perspectives.
Kehrli J, Husser C, Ryckelynck M Biosensors (Basel). 2024; 14(8).
PMID: 39194605 PMC: 11352751. DOI: 10.3390/bios14080376.
Evolution and Impact of Nucleic Acid Amplification Test (NAAT) for Diagnosis of Coronavirus Disease.
Khan S, Rathod P, Gupta V, Khedekar P, Chikhale R Anal Chem. 2024; 96(20):8124-8146.
PMID: 38687959 PMC: 11112543. DOI: 10.1021/acs.analchem.3c05225.
PCR Independent Strategy-Based Biosensors for RNA Detection.
Li X, Wang H, Qi X, Ji Y, Li F, Chen X Biosensors (Basel). 2024; 14(4).
PMID: 38667193 PMC: 11048163. DOI: 10.3390/bios14040200.
Li J, Wang X, Chen L, Duan L, Tan F, Li K Rep Biochem Mol Biol. 2024; 12(3):425-437.
PMID: 38618265 PMC: 11015926. DOI: 10.61186/rbmb.12.3.425.